Study offers new insight into possible treatment for Lou Gehrig's disease (ALS)

Madely Health Headlines Commentary for June 13, 2014


Findings point toward one of first therapies for Lou Gehrig’s disease


Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral SclerosisJournal of Neuroscience, 2014; 34 (23): 8021 DOI: 10.1523/JNEUROSCI.4196-13.2014